Health Catalyst Inc. (HCAT) PT Lowered to $29 at Goldman Sachs
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Price: $1.63 -3.55%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Goldman Sachs analyst Cindy Motz lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $29.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Canaccord Downgrades Health Catalyst Inc. (HCAT) to Hold
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
